ijms-logo

Journal Browser

Journal Browser

Molecular Mechanisms Involved in the Chemopreventive and Anticancer Activity of Pentacyclic Triterpenes 2.0

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".

Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 12415

Special Issue Editor


E-Mail Website
Guest Editor
1. Departament of Pharmacology-Pharmacotherapy, Faculty of Pharmacy, Victor Babeş University of Medicine and Pharmacy Timisoara, 2nd EftimieMurgu Sq., 300041 Timişoara, Romania
2. Research Center for Pharmaco-Toxicological Evaluations, Faculty of Pharmacy, Victor Babes University of Medicine and Pharmacy, 2 Eftimie Murgu Street, 300041 Timisoara, Romania
Interests: drug analysis; drug product design and development; analytical technique; magnetic and metallic nanoparticles; polymeric nanoparticles; solid–lipid nanoparticles; drug–cyclodextrin inclusion; complexation; cell biology; biological active compounds; biomedical microbiology; biophysics; biochemistry
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

For thousands of years, plants have provided therapeutic solutions for numerous pathologies initially in the form of raw extracts and then as source of active compounds which served as a starting point for the synthesis of new drugs. A significant share of existing small-molecule drugs, including certain anticancer medications, are directly derived or inspired by phytochemicals. Natural compounds may offer advantages over synthetic ones in terms of fewer and less severe side effects as well as reduced drug resistance. However, despite global efforts, the in vitro studies conducted on several phytocompounds have often resulted in unreliable information which could not support their clinical use under the current medical regulations. Therefore, rigorous scientific research must continue in order to assess the efficacy and safety of natural compounds as pharmacologically active agents.

This Special Issue is dedicated to the investigation of molecular mechanisms involved in the anticancer activity of pentacyclic triterpenes and their semisynthetic derivatives based on in vitro and in vivo studies. Pentacyclic triterpenes are secondary plant metabolites found in a wide variety of species with documented anti-inflammatory, anticancer, analgesic, and immunomodulatory effects. The chemical scaffold of pentacyclic triterpenes provides a promising platform for the synthesis of semisynthetic derivatives with improved pharmacokinetics and bioavailability.

Pentacyclic triterpenoids are able to act on multiple molecular targets and to regulate several cell proliferation pathways involved in the process of uncontrolled cell proliferation. In vitro and in vivo studies have shown that triterpenoids inhibit DNA polymerase, interfere with angiogenesis and cell differentiation, induce cell death through apoptosis, inhibit nuclear factor-κB (NF-κB) activation and signal transduction, and induce mitochondrial dysfunction, resulting in overall inhibition of proliferation and metastasis. Trit­erpenoid acids, monoalcohols, and diols exert antioxidant effects by reducing the production of free reactive oxidative species (ROS). Despite the identification of numerous molecular targets, detailed investigations are still needed in order to clarify the anticancer potential of this class of phytocompounds. In addition, given the sometimes contradictory results between in vitro and in vivo studies, more in vivo assessments are required to support in vitro findings. Systematic toxicological studies that are scientifically designed according to international guidelines are needed to accelerate the pharmaceutical development of triterpenoid compounds.

This Special Issue will collect a selection of recent research topics and current review articles related to the molecular mechanisms involved in the anticancer effects of pentacyclic triterpenoids in order to update the current knowledge in this field. Original papers, up-to-date review articles, short communications, and commentaries are all welcome.

Prof. Dr. Codruta Soica
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pentacyclic triterpenes
  • in vitro studies
  • in vivo studies
  • molecular mechanisms
  • semisynthetic derivatives
  • molecular targets
  • proliferation and metastasis inhibition

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (4 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

23 pages, 2996 KiB  
Article
Synthesis, Biological Activity, ADME and Molecular Docking Studies of Novel Ursolic Acid Derivatives as Potent Anticancer Agents
by Olga Michalak, Marcin Cybulski, Wojciech Szymanowski, Agnieszka Gornowicz, Marek Kubiszewski, Kinga Ostrowska, Piotr Krzeczyński, Krzysztof Bielawski, Bartosz Trzaskowski and Anna Bielawska
Int. J. Mol. Sci. 2023, 24(10), 8875; https://doi.org/10.3390/ijms24108875 - 17 May 2023
Cited by 3 | Viewed by 2226
Abstract
A series of new ursolic acid (UA) derivatives substituted with various amino acids (AAs) or dipeptides (DP) at the C-3 position of the steroid skeleton was designed and synthesized. The compounds were obtained by the esterification of UA with the corresponding AAs. The [...] Read more.
A series of new ursolic acid (UA) derivatives substituted with various amino acids (AAs) or dipeptides (DP) at the C-3 position of the steroid skeleton was designed and synthesized. The compounds were obtained by the esterification of UA with the corresponding AAs. The cytotoxic activity of the synthesized conjugates was determined using the hormone-dependent breast cancer cell line MCF-7 and the triple-negative breast cancer cell line MDA. Three derivatives (l-seryloxy-, l-prolyloxy- and l-alanyl-l-isoleucyloxy-) showed micromolar IC50 values and reduced the concentrations of matrix metalloproteinases 2 and 9. Further studies revealed that for two compounds (l-seryloxy- and l-alanyl-l-isoleucyloxy-), a possible mechanism of their antiproliferative action is the activation of caspase-7 and the proapoptotic Bax protein in the apoptotic pathway. The third compound (l-prolyloxy- derivative) showed a different mechanism of action as it induced autophagy as measured by an increase in the concentrations of three autophagy markers: LC3A, LC3B, and beclin-1. This derivative also showed statistically significant inhibition of the proinflammatory cytokines TNF-α and IL-6. Finally, for all synthesized compounds, we computationally predicted their ADME properties as well as performed molecular docking to the estrogen receptor to assess their potential for further development as anticancer agents. Full article
Show Figures

Figure 1

21 pages, 6031 KiB  
Article
Novel Triterpenic Acid—Benzotriazole Esters Act as Pro-Apoptotic Antimelanoma Agents
by Marius Mioc, Alexandra Mioc, Alexandra Prodea, Andreea Milan, Mihaela Balan-Porcarasu, Roxana Racoviceanu, Roxana Ghiulai, Gheorghe Iovanescu, Ioana Macasoi, George Draghici, Cristina Dehelean and Codruta Soica
Int. J. Mol. Sci. 2022, 23(17), 9992; https://doi.org/10.3390/ijms23179992 - 1 Sep 2022
Cited by 12 | Viewed by 2188
Abstract
Pentacyclic triterpenes, such as betulinic, ursolic, and oleanolic acids are efficient and selective anticancer agents whose underlying mechanisms of action have been widely investigated. The introduction of N-bearing heterocycles (e.g., triazoles) into the structures of natural compounds (particularly pentacyclic triterpenes) has yielded semisynthetic [...] Read more.
Pentacyclic triterpenes, such as betulinic, ursolic, and oleanolic acids are efficient and selective anticancer agents whose underlying mechanisms of action have been widely investigated. The introduction of N-bearing heterocycles (e.g., triazoles) into the structures of natural compounds (particularly pentacyclic triterpenes) has yielded semisynthetic derivatives with increased antiproliferative potential as opposed to unmodified starting compounds. In this work, we report the synthesis and biological assessment of benzotriazole esters of betulinic acid (BA), oleanolic acid (OA), and ursolic acid (UA) (compounds 13). The esters were obtained in moderate yields (28–42%). All three compounds showed dose-dependent reductions in cell viability against A375 melanoma cells and no cytotoxic effects against healthy human keratinocytes. The morphology analysis of treated cells showed characteristic apoptotic changes consisting of nuclear shrinkage, condensation, fragmentation, and cellular membrane disruption. rtPCR analysis reinforced the proapoptotic evidence, showing a reduction in anti-apoptotic Bcl-2 expression and upregulation of the pro-apoptotic Bax. High-resolution respirometry studies showed that all three compounds were able to significantly inhibit mitochondrial function. Molecular docking showed that compounds 13 showed an increase in binding affinity against Bcl-2 as opposed to BA, OA, and UA and similar binding patterns compared to known Bcl-2 inhibitors. Full article
Show Figures

Figure 1

Review

Jump to: Research

48 pages, 5226 KiB  
Review
Recent Advances Regarding the Molecular Mechanisms of Triterpenic Acids: A Review (Part II)
by Marius Mioc, Alexandra Prodea, Roxana Racoviceanu, Alexandra Mioc, Roxana Ghiulai, Andreea Milan, Mirela Voicu, Gabriel Mardale and Codruța Șoica
Int. J. Mol. Sci. 2022, 23(16), 8896; https://doi.org/10.3390/ijms23168896 - 10 Aug 2022
Cited by 12 | Viewed by 3649
Abstract
Triterpenic acids are a widespread class of phytocompounds which have been found to possess valuable therapeutic properties such as anticancer, anti-inflammatory, hepatoprotective, cardioprotective, antidiabetic, neuroprotective, lipolytic, antiviral, and antiparasitic effects. They are a subclass of triterpenes bearing a characteristic lipophilic structure that imprints [...] Read more.
Triterpenic acids are a widespread class of phytocompounds which have been found to possess valuable therapeutic properties such as anticancer, anti-inflammatory, hepatoprotective, cardioprotective, antidiabetic, neuroprotective, lipolytic, antiviral, and antiparasitic effects. They are a subclass of triterpenes bearing a characteristic lipophilic structure that imprints unfavorable in vivo properties which subsequently limit their applications. The early investigation of the mechanism of action (MOA) of a drug candidate can provide valuable information regarding the possible side effects and drug interactions that may occur after administration. The current paper aimed to summarize the most recent (last 5 years) studies regarding the MOA of betulinic acid, boswellic acid, glycyrrhetinic acid, madecassic acid, moronic acid, and pomolic acid in order to provide scientists with updated and accessible material on the topic that could contribute to the development of future studies; the paper stands as the sequel of our previously published paper regarding the MOA of triterpenic acids with therapeutic value. The recent literature published on the topic has highlighted the role of triterpenic acids in several signaling pathways including PI3/AKT/mTOR, TNF-alpha/NF-kappa B, JNK-p38, HIF-α/AMPK, and Grb2/Sos/Ras/MAPK, which trigger their various biological activities. Full article
Show Figures

Figure 1

50 pages, 7572 KiB  
Review
Recent Advances Regarding the Molecular Mechanisms of Triterpenic Acids: A Review (Part I)
by Marius Mioc, Andreea Milan, Daniel Malița, Alexandra Mioc, Alexandra Prodea, Roxana Racoviceanu, Roxana Ghiulai, Andreea Cristea, Florina Căruntu and Codruța Șoica
Int. J. Mol. Sci. 2022, 23(14), 7740; https://doi.org/10.3390/ijms23147740 - 13 Jul 2022
Cited by 31 | Viewed by 3869
Abstract
Triterpenic acids are phytocompounds with a widespread range of biological activities that have been the subject of numerous in vitro and in vivo studies. However, their underlying mechanisms of action in various pathologies are not completely elucidated. The current review aims to summarize [...] Read more.
Triterpenic acids are phytocompounds with a widespread range of biological activities that have been the subject of numerous in vitro and in vivo studies. However, their underlying mechanisms of action in various pathologies are not completely elucidated. The current review aims to summarize the most recent literature, published in the last five years, regarding the mechanism of action of three triterpenic acids (asiatic acid, oleanolic acid, and ursolic acid), corelated with different biological activities such as anticancer, anti-inflammatory, antidiabetic, cardioprotective, neuroprotective, hepatoprotective, and antimicrobial. All three discussed compounds share several mechanisms of action, such as the targeted modulation of the PI3K/AKT, Nrf2, NF-kB, EMT, and JAK/STAT3 signaling pathways, while other mechanisms that proved to only be specific for a part of the triterpenic acids discussed, such as the modulation of Notch, Hippo, and MALAT1/miR-206/PTGS1 signaling pathway, were highlighted as well. This paper stands as the first part in our literature study on the topic, which will be followed by a second part focusing on other triterpenic acids of therapeutic value. Full article
Show Figures

Figure 1

Back to TopTop